Shockwave Medical to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

Shockwave Medical, a pioneer in Intravascular Lithotripsy (IVL) for treating calcified cardiovascular disease, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1 to 3, 2020. Their management is set for a live fireside chat on December 2, 2020, at 8:30 a.m. Eastern Time. The event will be available via webcast on the company's website. Shockwave aims to revolutionize treatment for atherosclerotic cardiovascular disease, offering a minimally invasive solution that enhances patient outcomes through the localized delivery of sonic pressure waves.

SANTA CLARA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, announced today that it will be participating in the Piper Sandler 32nd Annual Virtual Healthcare Conference, scheduled to be held December 1 to 3, 2020.

Shockwave's management is scheduled for a live fireside chat on Wednesday, December 2, 2020, at 8:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the event on the "Investors" section of the company’s website at https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.

Shockwave Medical is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. The company aims to establish a new standard of care for the interventional treatment of atherosclerotic cardiovascular disease through differentiated and proprietary local delivery of sonic pressure waves for the treatment of calcified plaque, which the company refers to as Intravascular Lithotripsy (IVL). IVL is a minimally invasive, easy-to-use and safe way to significantly improve patient outcomes. To view an animation of the IVL procedure and for more information, visit www.shockwavemedical.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
investors@shockwavemedical.com

 

FAQ

When will Shockwave Medical participate in the Piper Sandler Virtual Healthcare Conference?

Shockwave Medical will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference from December 1 to 3, 2020.

What time is Shockwave Medical's fireside chat during the conference?

Shockwave Medical's management will have a fireside chat on December 2, 2020, at 8:30 a.m. Eastern Time.

Where can I access the livestream of Shockwave Medical's event?

The live and archived webcast of Shockwave Medical's event can be accessed on the 'Investors' section of their website.

What is Intravascular Lithotripsy (IVL) developed by Shockwave Medical?

Intravascular Lithotripsy (IVL) is a treatment method that uses sonic pressure waves to treat calcified plaque in arteries, aiming to improve patient outcomes.

How does Shockwave Medical aim to impact cardiovascular disease treatment?

Shockwave Medical aims to set a new standard of care for interventional treatments for atherosclerotic cardiovascular disease through its IVL technology.